News
Explore the latest stories and publications from NCATS and our partners, see upcoming events, or explore the variety of resources we provide to better understand translational science and our work.
News
Read the latest news from NCATS and its collaborators whose research is supported through the Center’s programs, or follow coverage of NCATS' translational research activities through national and local media.
Digital Reminiscence App Could Reduce Grief and Improve Relationships Between Dementia Patients and Caregivers
April 22, 2026 - Grantee/Partner News
- Clinical and Translational Science Awards (CTSA) Program
TRIumph Program Uses Communication to Connect Science to Community
April 22, 2026 - Grantee/Partner News
- Clinical and Translational Science Awards (CTSA) Program
Ketogenic Diet Leads to Cognitive Improvement in Patients with Mild Alzheimer’s Disease
March 22, 2022 - NCATS News
- Clinical and Translational Science Awards (CTSA) Program
CTSA Program-supported researchers tested the hypothesis that ketones could provide a new source of energy for the brain in people with Alzheimer’s disease (AD). The study found improved brain function in people with mild AD after a three-month ketogenic diet.
NCATS-Supported Research Reduces Time to Diagnosis for Seriously Ill Children with Genetic Diseases
March 11, 2022 - NCATS News
- Clinical and Translational Science Awards (CTSA) Program
NCATS-supported researchers have developed an automated approach to diagnosis of genetic diseases in seriously ill children to allow faster diagnosis and initiation of treatment, and, ultimately, better outcomes. The study appeared in the April 24, 2019, issue of Science Translational Medicine.
NIH-Funded Study Suggests COVID-19 Increases Risk of Pregnancy Complications
February 7, 2022 - NCATS News
- Clinical and Translational Science Awards (CTSA) Program
Pregnant women with COVID-19 appear to be at greater risk for common pregnancy complications — in addition to health risks from the virus — than pregnant women without COVID-19, suggests a study funded by NIH. The study, supported in part by NCATS, included nearly 2,400 pregnant women infected with SARS-CoV-2 and found that those with moderate to severe infection were more likely to have a cesarean delivery, to deliver preterm, to die around the time of birth, or to experience serious illness from hypertensive disorders of pregnancy, postpartum hemorrhage or from infection other than SARS-CoV-2.
International Registry Reveals Risks COVID-19 Poses with Sickle Cell Disease
February 1, 2022 - NCATS News
- COVID-19
- Clinical and Translational Science Awards (CTSA) Program
NCATS-funded CTSA Program researchers developed a collaborative registry that collects data on COVID-19 illness in people with sickle cell disease.
Statement on NIH Study Testing Convalescent Plasma in Hospitalized Patients
January 11, 2022 - NCATS News
- Clinical and Translational Science Awards (CTSA) Program
Findings from NIH’s Convalescent Plasma to Limit COVID-19 Complications in Hospitalized Patients trial show that convalescent plasma taken from people who had recovered from COVID-19 was not more effective than placebo in delivering clinical improvement 14 days and 28 days after treatment began for people hospitalized with COVID-19.
Fatal Heart Attack or Stroke Could Be First Sign of CVD in Some Smokers
November 17, 2021 - Grantee/Partner News
- Clinical and Translational Science Awards (CTSA) Program